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The human cerebral cortex contains many cell types that likely
underwent independent functional changes during evolution. How-
ever, cell-type–specific regulatory landscapes in the cortex remain
largely unexplored. Here we report epigenomic and transcriptomic
analyses of the two main cortical neuronal subtypes, glutamatergic
projection neurons and GABAergic interneurons, in human, chimpan-
zee, and rhesus macaque. Using genome-wide profiling of the
H3K27ac histone modification, we identify neuron-subtype–specific
regulatory elements that previously went undetected in bulk brain
tissue samples. Human-specific regulatory changes are uncovered in
multiple genes, including those associated with language, autism
spectrum disorder, and drug addiction. We observe preferential evo-
lutionary divergence in neuron subtype-specific regulatory elements
and show that a substantial fraction of pan-neuronal regulatory el-
ements undergoes subtype-specific evolutionary changes. This study
sheds light on the interplay between regulatory evolution and cell-
type–dependent gene-expression programs, and provides a resource
for further exploration of human brain evolution and function.
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Among the numerous phenotypic differences between humansand other primates, the most striking are specializations of
social and cognitive abilities, including language and executive
function, such as abstract reasoning, planning, behavioral inhibi-
tion, and understanding mental states of others (1). It has been
hypothesized that the evolutionary changes associated with the
unique features of human cognition reside, primarily, in the
neocortex (2). The neocortex contains multiple cell types, in-
cluding two major classes of neurons, the excitatory glutamatergic
(Glu) projection neurons and the inhibitory GABAergic inter-
neurons, which account for about 70 to 80% and 20 to 30% of all
cortical neurons, respectively (3–5). The specification and main-
tenance of these neurons are determined by transcriptional pro-
grams that are themselves controlled by the activity of gene
regulatory elements (GRE), such as promoters and enhancers (6).
GREs recruit transcription factors and chromatin modifiers to
control the expression of genes in a cell-type–dependent manner
(7). Multiple lines of evidence suggest that phenotypic variation
among mammals and susceptibility to brain diseases are largely
due to changes in GREs rather than protein-coding sequences
(8, 9). Indeed, enhancer changes could cause tissue- or cell-
type–dependent adaptations without causing pleiotropic effects
that are often associated with changes to genes (10, 11). There-
fore, to understand the molecular and cellular differences in brain
organization between human and other primates better, it is es-
sential to characterize the mechanisms that drive GRE evolution
in individual cell types.
Previous studies used chromatin immunoprecipitation fol-
lowed by sequencing (ChIP-seq) to assess evolutionary changes
of GREs marked by covalent histone modifications in bulk brain
tissue (12–14). However, information on key evolutionary
changes that could affect the human brain thus far remains
limited. One reason is that regulatory changes affecting a par-
ticular cell type cannot be reliably inferred from data on bulk
brain specimens that conflate signals from all cell types. Mixed
signals in bulk specimens likely mask signatures of lower abun-
dance cells (e.g., GABA neurons). In contrast to bulk tissue
analysis, single-cell ChIP-seq techniques that are currently under
development lack sufficient coverage to reliably detect regula-
tory elements (15, 16). To provide insight into the cell-
type–dependent changes that underlie evolution of the human
neocortex, we used fluorescence-activated nuclei sorting (FANS)
to isolate cortical Glu and GABA neuronal nuclei obtained from
one of our closest extant relatives, chimpanzee, and a commonly
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studied nonhuman primate, rhesus macaque, followed by ChIP-
seq and RNA-sequencing (RNA-seq) analyses of the epigenome
and trancriptome (17, 18). We integrated these data with com-
plementary human transcriptomes and ChIP-seq data from sor-
ted Glu and GABA neurons (19).
We identified numerous GREs that have not been detected in
bulk brain specimens, many of which have neuron subtype-
specific and species-specific enrichment for histone modifica-
tions. We found strong evidence of concordant evolutionary
changes in expression and epigenetic regulation for ∼200 genes,
highlighting the functional importance of regulatory evolution in
neuronal subtypes. These include genes involved in opioid sig-
naling and drug abuse (OPRM1, PENK, SLC17A8) (20–22), as
well as genes associated with language impairments (ATP2C2,
DCDC2) (23). We also found neuron subtype- and human-
enriched regulatory elements in two genes that are considered
among the strongest candidates for enabling or facilitating lan-
guage abilities, FOXP2 and CNTNAP2 (24–26), and identified
large clusters of human-specific GREs near genes implicated in
neuronal function and brain disorders (e.g., CDH8, ASTN2,
CNTNAP4) (27–29). Furthermore, we demonstrated that cell-
type–specific GREs are more likely to change their activity
during primate evolution than GREs shared by different cell
types, and found that positional conservation of a GRE in dif-
ferent cell types is not always associated with functional con-
servation. Our findings provide insight into regulatory evolution
that is relevant for brain function and disorders, and present a
resource for future studies on comparative epigenomics and
neuroscience.
Results
Epigenomic Profiling of Glu and Medial Ganglionic Eminence-GABA
Neurons from Primate Brains Reveals Extensive Differences in
Regulatory Landscapes between Neuronal Subtypes. FANS allows
separation and acquisition of nuclei from Glu and medial gan-
glionic (MGE)-derived GABA neurons (MGE-GABA) from
autopsied cortical samples (17, 19) (Fig. 1A). MGE-GABA
neurons comprise ∼60 to 70% of all neocortical GABA neurons
and have been implicated in schizophrenia, major depression,
autism spectrum disorder (ASD), and epilepsy (30, 31). We re-
cently reported RNA-seq transcriptome profiling and ChIP-seq
analysis of histone 3 lysine 27 acetylation (H3K27ac) in Glu and
MGE-GABA nuclei that were obtained from the dorsolateral
prefrontal cortex (DLPFC) (19). H3K27ac is a robust marker of
active promoters and enhancers (32, 33). The DLPFC is the
neocortical region that is important for cognition and executive
function (1). To investigate regulatory changes across primate
evolution, we performed H3K27ac ChIP-seq in Glu and MGE-
GABA nuclei from four male chimpanzee and four rhesus ma-
caque DLPFC, and integrated these datasets with our previously
obtained data for humans (19) (Dataset S1).
We produced high-quality H3K27ac ChIP-seq datasets
(Dataset S2), with biological replicates showing strong correla-
tion in each cell type and species (all correlation coefficients, r >
0.8) (SI Appendix, Fig. S1A). Well-established Glu markers (e.g.,
SLC17A7, TBR1) were enriched in H3K27ac specifically in Glu
neurons, whereas typical MGE-GABA markers (e.g., LHX6,
SOX6) were enriched in MGE-GABA neurons only (Fig. 1 B–D
and SI Appendix, Fig. S1 B–D). We defined putative GREs as
regions (peaks) of histone acetylation that were significantly
enriched over the background in at least three of the four do-
nors, detecting a comparable number of GREs (∼100,000) in at
least one neuronal subtype in each species (hereafter, Glu or
MGE-GABA GREs) (Methods and Dataset S3). We then iden-
tified GREs that were differentially acetylated (DA) between
neuronal subtypes in each species separately, focusing on the
subset of GREs with the strongest cell type differences (fold
change [FC] > 2, false-discovery rate [FDR] < 0.05) (Methods,
SI Appendix, Fig. S1E, and Dataset S4). We then subdivided GRE
regions into proximal H3K27ac peaks (within 1 kb from annotated
transcriptional start sites in the human genome), which are indic-
ative of active promoters, and distal H3K27ac peaks, which are
indicative of active enhancers. We confirmed the previously ob-
served greater regulatory diversity of enhancers vs. promoters,
detecting significant differential acetylation between cell types in 48
to 61% of enhancers vs. 12 to 17% of promoters (Fig. 1E) (11). A
substantial proportion of all active neuronal GREs (promoters and
enhancers) was DA between Glu and MGE-GABA neurons
(ranging from 43 to 56% in different species), with a comparable
ratio of DA GREs between the neuronal subtypes in each species
(SI Appendix, Fig. S1E). Gene ontology (GO) analysis using
GREAT (Genomic Regions Enrichment of Annotations Tool)
(34) validated the cell type-specificity and functional relevance of
the regulatory elements we identified (Dataset S5).
To test whether the cell-type–specific approach increases the
sensitivity and resolution of GRE analysis, we compared the
human Glu and MGE-GABA enhancers in the DLPFC with
enhancers that were previously identified in bulk human tissues
from several brain regions (cortex, cerebellum, and subcortical
regions) using H3K27ac ChIP-seq (12, 35). Over 40% of non-DA
enhancers but only ∼20% of either Glu or MGE-GABA DA
enhancers had been previously identified in bulk cortex (Fig. 1F).
Despite a higher proportion of Glu vs. MGE-GABA neurons in
the cortex, a comparable fraction of Glu DA and MGE-GABA
DA enhancers was not detected in bulk cortical tissue. This is
likely explained by the large number of unique subpopulations of
cortical Glu neurons, which were recently uncovered in single-
nucleus RNA-seq analyses (36). In contrast, the MGE-derived
GABA neurons represent a less diverse subset of cortical neu-
rons (36). Our approach also enables the assignment of neuron-
subtype specificity for GREs that were previously detected in
bulk brain tissues. For example, the human MYC enhancer that
was previously found to be both human-specific and cortex-
specific (12), is exclusively active in Glu but not in MGE-
GABA neurons (Fig. 1G).
Substantial Regulatory Changes in Glu and MGE-GABA Cortical Neurons
during Primate Evolution. To enable the comparison of the
H3K27ac datasets from different species, coordinates of Glu and
MGE-GABA H3K27ac-enriched regions from chimpanzee and
rhesus macaque were converted to the hg38 human genome as-
sembly using liftOver (12) (Methods). Regions with overlapping
coordinates were merged (n = 110,270 for Glu; n = 91,560 for
MGE-GABA), and liftOver was used again to convert the coor-
dinates to panTro5 and rheMac8. Only GREs that could be
mapped onto all three genomes and did not overlap blacklisted
regions were included in the subsequent analyses (99,339 Glu and
82,761 MGE-GABA GREs) (Methods and Dataset S6). We
compared the H3K27ac signals within GREs between the species
and neuronal subtypes using Pearson correlation, hierarchical
clustering, and principal component analysis (PCA) (Methods,
Fig. 1H, and SI Appendix, Fig. S1 F and G). Based on correlation
and clustering analyses, we detected greater differences between
cell types in each species compared with the differences between
species in each cell type. Clustering and PCA showed a clear
separation of samples into six groups according to cell type and
species, with human and chimpanzee clustering closer together vs.
rhesus macaque in each cell type.
To investigate the regulatory changes during primate evolu-
tion, we analyzed H3K27ac levels within the GREs that were DA
between species in each neuronal subtype in pairwise compari-
sons (i.e., species-enriched GREs) (Methods, Fig. 1 I and J, SI
Appendix, Fig. S1H, and Dataset S7). In both Glu and MGE-
GABA, ∼14 to 16% of promoters (2,146 in Glu and 1,754 in
MGE-GABA) and ∼34 to 38% of enhancers (32,785 in Glu and
23,435 in MGE-GABA) were DA in human vs. rhesus macaque
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Fig. 1. Regulatory changes in Glu and MGE-GABA neurons during primate evolution. (A) Schematic of isolation of Glu and MGE-GABA nuclei. (B–D) H3K27ac
ChIP-seq profiles for Hu (B), Ch (C), and Rh (D) at the loci of Glu (SLC17A7, Left) and MGE-GABA (LHX6, Right) markers. Read per million (RPM)-normalized
reads (axis limit 3 RPM). (E) Fractions of promoters or enhancers that are Glu DA, MGE-GABA DA or non-DA in Glu vs. MGE-GABA. (F) Fractions of Glu DA,
MGE-GABA DA, and non-DA Hu enhancers that overlap GREs in bulk prefrontal cortex (PFC) tissue (12). ***P < 0.0005 (Fisher’s exact test). (G) The regulatory
landscapes near the MYC locus in bulk PFC (12) (Left) and in Glu and MGE-GABA neurons (Right). (H) PCA of ChIP-seq data for Glu and MGE-GABA neurons
from Hu, Ch, and Rh. (I) Schematic of pairwise interspecies comparisons between the ChIP-seq datasets. (J) Fractions of Glu DA, MGE-GABA DA, and non-DA
GREs in pairwise species comparisons; Glu (Upper) and MGE-GABA (Lower) neurons.





















(FDR < 0.05, FC > 2) (Fig. 1J). Consistent with the closer evo-
lutionary relationship between human and chimpanzee, there
were fewer DA promoters (896 in Glu and 609 in MGE-GABA)
and enhancers (15,625 in Glu and 8,495 in MGE-GABA) between
human and chimpanzee. Thus, using a cell-type–specific analysis,
we showed that, in each neuronal subtype, ∼30% of the GREs
underwent significant changes in primate evolution. Examples of
such regulatory changes are shown in SI Appendix, Fig. S1I.
Neuron Subtype–Specific Regulatory Elements Change more Frequently
during Evolution than Nonspecific Ones. Previous work in bulk brain
tissues has shown that evolutionary changes preferentially occur in
GREs that are mainly active in a single brain region (cortex,
midbrain, or cerebellum), but not in multiple structures (12). This
result fits a model in which changes in GREs that are not region-
specific are more likely to cause pleiotropic effects, which might be
detrimental to the fitness of the organism and are, therefore,
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Fig. 2. Evolutionary changes in neuron subtype-specific and pan-neuronal regulatory elements. (A) Cell type specificity of Hu > Rh DA (green boxes) or non-
DA (white boxes) GREs. GREs detected in Glu (Left) or MGE-GABA (Right) neurons in Hu and/or Rh. Pie charts indicate fractions of DA (brown) or non-DA
(gray) GREs between neuronal subtypes in Hu. In both neuronal subtypes, Hu > Rh DA GREs were more often neuron-subtype-specific than non-DA GREs (P <
2.2e-16; Fisher’s exact test). (B) Venn diagram of the overlap between Glu and MGE-GABA enhancers in Hu and/or Rh. The overlapping enhancers (dark blue)
are positionally shared in Glu and MGE-GABA neurons (pan-neuronal). (C) Schematic of possible evolutionary changes in pan-neuronal enhancers in Hu and/
or Rh. Gray, no evolutionary change in any neuronal subtype; orange, same direction of an evolutionary change in both subtypes; yellow, an evolutionary
change in only one subtype; purple, different direction of an evolutionary change between subtypes (respecification). (D) Simultaneous cross-species and
cross-cell–type analysis of H3K27ac signal intensities for pan-neuronal enhancers in Hu and/or Rh (Methods and SI Appendix, Fig. S2C). Shown are DA GREs
confirmed by the analysis to undergo the type of an evolutionary change described in C. (E–G) Examples of enhancers (dashed boxes) with the same direction
of evolutionary change in Glu and MGE-GABA (E, the PTCH2 locus), with an evolutionary change in only one neuronal subtype, MGE-GABA (F, near MEF2A),
and with evolutionary changes in opposite directions in Glu and MGE-GABA neurons (respecification) (G, the POLQ locus).




























selected against during evolution. We hypothesized that this trend
also extends to evolutionary changes in the activity of cell-type–
enriched GREs. Only a limited number of GREs have changed
between human and chimpanzee, precluding a reliable statistical
analysis. We therefore assembled two sets of GREs that were
detected in human and/or rhesus macaque in each neuronal
subtype (93,222 for Glu and 79,181 for MGE-GABA), and com-
pared cell-type specificity of DA and non-DA GREs between the
two species (Fig. 2A). We found that DA GREs were significantly
more often cell type-specific than non-DA ones (Fisher’s exact
test, P < 2.2e-16; odds ratios: 2.8 for Glu and 2.2 for MGE-
GABA). Conversely, human GREs that were non-DA between
neuronal subtypes were significantly less frequently DA between
the two species compared to GREs that were DA between Glu
and MGE-GABA (Fisher’s exact test, P < 2.2e-16) (SI Appendix,
Fig. S2A).
To further validate this finding, we used a threshold-free ap-
proach by directly comparing the enrichment of enhancers in
neuronal subtypes (e.g., difference between Glu and MGE-GABA
in human, ΔCellTypehuman =H3K27acGlu,human −H3K27acGABA,human)
vs. the evolutionary change (e.g., difference between human and
macaque in Glu cells, ΔSpeciesGlu = H3K27acGlu,human −
H3K27acGlu,rhesus) (Methods). This analysis used independent
biological samples to estimate H3K27acGlu,human at each step of
the analysis, to avoid spurious correlations driven by noise in
individual datasets. Across all enhancers detected in human Glu
cells, we found a significant correlation between the cell type-
specificity and the evolutionary change (Spearman r = 0.203, P <
1e-16) (SI Appendix, Fig. S2 B, Upper). No such correlation was
observed when the enhancers were randomly shuffled. A similar
pattern was observed in human MGE-GABA cells (r = 0.106,
P < 1e-16) (SI Appendix, Fig. S2 B, Lower). These analyses
confirm that evolutionary divergence of neuronal enhancers
preferentially occurs in a cell-type–specific manner.
Pan-Neuronal Enhancers Undergo Neuron Subtype-Specific Evolutionary
Changes. Whereas GREs active in both Glu and MGE-GABA
(hereafter, pan-neuronal GREs) are more often evolutionarily
conserved between human and rhesus macaque than cell-
type–specific ones, a substantial proportion of pan-neuronal
GREs change in at least one neuronal subtype (SI Appendix,
Fig. S2A). Thus, our data offered a unique opportunity to com-
pare the evolution of enhancers that are active in at least two
closely related cell types. We found that, among these shared
enhancers (n = 35,676) (dark purple in Fig. 2B), 19,225 (∼54%)
showed no evolutionary changes (gray panel in Fig. 2C), whereas
the rest (n = 16,451) changed between the species in at least one
cell type (DA analyses between human and rhesus macaque in Glu
or MGE-GABA, FC > 2; FDR < 0.05) (yellow, orange, and
purple panels in Fig. 2C). We then asked whether evolutionary
changes in the latter group were similar in Glu vs. MGE-GABA
neurons. We categorized the enhancers into 1) enhancers with the
same direction of evolutionary change in both Glu and MGE-
GABA neurons (orange panels in Fig. 2C), 2) enhancers with an
evolutionary change in only one cell type (yellow panels in
Fig. 2C), and 3) enhancers with evolutionary changes of opposite
directions in Glu and MGE-GABA neurons. The latter group
represents a small subset of enhancers that may be functionally
respecified (12, 37), with activity switching from one neuronal
subtype in one species to a different neuronal subtype in another
species (purple panels in Fig. 2C). We used a linear model to
further assess the statistical significance of these evolutionary
events, assigning events to several categories depending on the
proportion of variance explained by the corresponding factor (η2)
and the FDR value (Methods and SI Appendix, Fig. S2C). By
overlapping the results of this analysis with the DA analysis
(Fig. 2C), we identified 3,074 enhancers that changed in the same
direction in both cell types, 2,425 enhancers that changed in one
but not in the other cell type, and 100 enhancers that underwent a
respecification (Fig. 2D and Dataset S8).
Examples of these three types of evolutionary events are
highlighted in Fig. 2 E–G. The enhancer in the PTCH2 locus
showed increased activity in human vs. rhesus macaque in both
neuronal subtypes (Fig. 2E). Another enhancer, located ∼60 kb
upstream of the MEF2A promoter, illustrates an evolutionary
change that occurred in only one cell type. The pan-neuronal
activity of this enhancer in rhesus macaque is contrasted with
strictly Glu-specific H3K27ac signal in human (Fig. 2F). Finally,
an enhancer in the POLQ locus provides a rare example of
respecification, as it is Glu-specific in human and MGE-
GABA–specific in rhesus macaque (Fig. 2G). Altogether, these
results indicate that enhancers in conserved genomic positions
between species in the same tissue can undergo different evolu-
tionary changes in different cell types. Therefore, positional con-
servation of an enhancer is not always a reliable proxy for its
functional conservation, suggesting that variation of enhancer
activity between cell types is most likely greater than can be
inferred based on positional conservation alone.
Concordant Evolutionary Changes in GREs and Gene Expression
Underscore Functional Relevance of Regulatory Evolution in Neuronal
Subtypes. We next examined how the evolutionary changes in the
regulatory landscape of the neuronal subtypes are reflected in
changes in gene expression. We performed RNA-seq on FANS-
separated Glu and MGE-GABA nuclei purified from the same
DLPFC specimens that were used for the H3K27ac profiling
(Dataset S1), obtaining high-quality transcriptomes for each spe-
cies and cell type (Methods, SI Appendix, Fig. S3 A–E, and Dataset
S9). In agreement with previous findings in various bulk tissues
and species (38), the expression of protein-coding genes (n =
16,846) was much more conserved between species than the ex-
pression of long intergenic noncoding RNA genes (n = 518) (SI
Appendix, Fig. S3F).
Next, in each neuronal subtype, we identified DA GREs and
differentially expressed (DE) genes that were enriched or de-
pleted in a particular species compared to the two other species
(Fig. 3 A, Left and SI Appendix, Fig. S3 G, Upper). We denoted
these up-regulated or down-regulated GREs or genes as species-
specific up- or down-DA GREs or DE genes. To focus on high-
confidence DA GREs and DE genes, we applied conservative
FC thresholds in both analyses (FC > 2, FDR < 0.05) (Methods,
SI Appendix, Fig. S3G, Lower, and Datasets S10–S12). We found
thousands of DA GREs and hundreds of DE genes for each
comparison, with the largest numbers of species-specific GREs
and genes detected in rhesus macaque (Fig. 3 B and C). The
analysis of DE genes showed that approximately half of the
genes that were species-specific in one neuronal subtype were
also specific for the same species in another neuronal subtype
(Dataset S12). In addition, for both neuronal subtypes, the
species-specific up-DE genes significantly overlapped with the
up-DE genes that have been recently reported for the same
species in sorted neuronal (NeuN+) nuclei from the DLPFC (11
to 31% overlap for Glu DE genes and 12 to 23% overlap for
MGE-GABA DE genes, P < 2.5e-6 by hypergeometric test)
(Dataset S13) (39). Also, our gene-expression data were in good
agreement with the results of human vs. rhesus macaque DE
analysis in bulk adult DLPFC reported by the PsychENCODE
consortium (17 to 19% overlap, P < 2.8e-14 by hypergeometric
test) (Dataset S14) (40).
We performed GO analysis for species-specific DE genes us-
ing Enrichr (41), as well as for genes located near species-specific
DA GREs using GREAT. The human-specific DE gene sets in
Glu or MGE-GABA neurons were not enriched for genes from
any functional GO categories; the chimpanzee-specific Glu DE
genes were enriched for a few GO terms, including “axon de-
velopment,” adjusted P = 0.014. (Dataset S15). Species-specific
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Fig. 3. Concordant evolutionary changes in GREs and gene expression. (A) Schematic of the analysis of association between species-specific up-regulated
GREs and genes. (Left) identification of species-specific DA GREs and DE genes. (Right) identification of concordant pairs of species-specific up-regulated DA
GREs and DE genes. (B) Numbers of species-specific up-regulated or down-regulated DA GREs detected in Glu or MGE-GABA neurons. (C) Numbers of species-
specific up-regulated or down-regulated DE genes. (D) Numbers of species-specific DE genes with concordant species-specific DA GREs. (E) Heatmap of
H3K27ac signal intensities and interspecies changes in gene expression for concordant pairs of Hu-specific up-DA GREs and up-DE genes. Shown are con-
cordant GRE-gene pairs in Glu (Upper) and MGE-GABA (Lower). K-means clustering of the H3K27ac signal in individual Hu, Ch, and Rh samples resulted in two
major clusters for each neuronal subtype, corresponding to neuron-subtype-specific or nonspecific GREs. Concordant promoter- and enhancer-gene pairs are
shown separately for each cluster. Heatmap colors indicate normalized H3K27ac signal intensities (rlog) for each replicate sample and log2 FC of normalized
RNA-seq reads (transcripts per million, TPM). (F) Mean interspecies changes of quantitative features of gene regulatory domains. The features are detailed on
the top of the panel. Shown are data for species-specific up-regulated concordant genes and for non-concordant genes. (G and H) Evolutionary changes in
regulation (G) and expression (H) for the CAT gene. (I and J) Same as in G and H for the SLC17A8 gene.




























GREs were enriched for gene sets from several GO terms;
however, the majority of these terms were not related to the
nervous system (Dataset S15). One exception was the enrichment
of the human-specific DA GREs in Glu neurons for the “regu-
lation of glutamate secretion” term (adjusted P value 0.019). Also
of interest were the results of GO analysis for the pairwise inter-
species comparisons (Dataset S15). In MGE-GABA neurons, the
GREs that were up-regulated in human vs. rhesus macaque were
significantly enriched for the “L-type voltage gated calcium
channels” term as well as for genes involved in “Wnt-activated
receptor activity.” The Wnt pathway-related genes (e.g., FZD8)
are known to influence cortical size (42, 43).
We then linked species-specific GREs to nearby genes using
GREAT (Methods) and overlapped the resulting gene sets with
genes showing species-specific expression (Fig. 3 A, Right, SI
Appendix, Fig. S3H, and Datasets S16 and S17). This analysis
yielded hundreds of genes with evidence of concordant species-
specific evolutionary changes in gene expression and in at least
one associated GRE (Fig. 3D). The fraction of species-specific
DE genes that had a concordant DA GRE varied for each species
and was in the range of 18 to 30% in human, 17 to 26% in
chimpanzee, and 40 to 53% in rhesus macaque for up- or down-
regulated DE genes in Glu or MGE-GABA (Dataset S18). We
used random shuffling (Methods) to assess statistical significance
of the observed concordant association between GREs and genes.
For all categories of concordant changes (species-specific up- or
down-regulated, Glu or MGE-GABA neurons, promoters or en-
hancers), concordant GRE-gene pairs were significantly overrep-
resented compared with random pairs (all Ps < 1e-7) (SI Appendix,
Fig. S3I), indicating that the genes linked to DA regulatory ele-
ments are more likely to be DE than expected by chance. Thus, a
sizable proportion of the identified concordant GRE-gene pairs
likely represents functional associations that underlie evolutionary
differences in gene expression between the primate species, rather
than resulting from coincidental colocalizations of species-specific
DA peaks and DE genes.
Among the concordant human up-DA GREs, ∼50 to 60%
were specific for Glu or MGE-GABA, whereas the remaining
group displayed a strong H3K27ac signal in both neuronal sub-
types (Fig. 3E). Separation of GREs into promoters and en-
hancers showed that the majority of genes with concordant
evolutionary changes in expression and promoter signal also had
an evolutionary change in at least one enhancer (70% in Glu and
64% in MGE-GABA) (SI Appendix, Fig. S3J). Finally, in all
three species, concordant genes often associated with multiple
concordant enhancers (23 to 45% of human- or chimpanzee-
specific and ∼60% of rhesus macaque-specific concordant up-
or down-regulated DE genes in Glu or MGE-GABA) (SI Ap-
pendix, Fig. S3K).
Whereas changes in promoter signals were associated with
larger changes in gene expression compared with changes in
enhancers (Fig. 3E and SI Appendix, Fig. S3L), the neuronal
regulatory landscapes often encompass more than one enhancer
per gene (6, 44). Therefore, we asked if additional quantitative
features that represent aggregate measures of an entire gene
regulatory domain (as defined by GREAT with the basal plus
extension setting) (Methods), such as the number of DA regu-
latory elements per gene (45) or the intensity of an enhancer
signal (maximum and sum), could provide independent valida-
tion of the functional evolutionary change in a concordant DA
enhancer-gene pair. We found that, in both neuronal subtypes,
each of these regulatory features significantly correlated with
gene expression (SI Appendix, Fig. S3 M and N) and that evo-
lutionary changes in these features were significantly correlated
with evolutionary changes in gene expression (Spearman corre-
lation, all Ps < 2.2e-16) (SI Appendix, Fig. S3 O and P). Finally,
we confirmed that the majority of the concordant enhancer-gene
pairs represent genes with an evolutionary change not only in
individual enhancer but also in the entire regulatory domain
(Fig. 3F). These gene sets, with their associated epigenetic fea-
tures, are compiled in Dataset S19, which provides a resource to
enable future hypothesis-driven functional and evolutionary
studies on primate brains.
Two representative examples of human-specific concordant
GRE-gene pairs are CAT and SLC17A8 loci (Fig. 3 G–J). CAT
encodes the hydrogen peroxide-degrading enzyme catalase. CAT
is more strongly expressed in Glu vs. MGE-GABA neurons and is
preferentially expressed in hominids (i.e., humans and chimpan-
zees) vs. rhesus macaque, with a significantly higher expression in
human vs. chimpanzee. In addition to the strong human-specific
H3K27ac enrichment in the promoter, we also detected an en-
richment in several Glu-specific CAT enhancers in human or
chimpanzee vs. rhesus macaque. Accumulation of H2O2 in oxi-
dative metabolism has been linked to oxidative-stress–associated
neurodegenerative disorders (46). Elevated expression of CAT in
human neurons could, therefore, reflect the evolution of protec-
tive mechanisms that limit oxidative damage resulting from the
higher metabolic activity of the human brain compared to that of
chimpanzee (47–49). SLC17A8 encodes vesicular glutamate
transporter 3 and is selectively up-regulated in human MGE-
GABA neurons, with corresponding gains in human-specific en-
hancers. SLC17A8 is implicated in cocaine abuse (22) as well as in
anxiety-related behaviors (50).
In line with earlier observations based on gene expression and
DNase I hypersensitivity data (51, 52), GO analysis of human-
specific concordant genes (enriched or depleted) resulted in no
enrichment for groups of genes with similar biological features.
The time span for evolutionary divergence between human and
chimpanzee is likely too short for groups of functionally related
genes to have coevolved (12, 52).
Evolutionary Changes in Regulation and Expression of Genes Associated
with Language Ability. One of the most striking differences between
humans and other primate species is language ability. We examined
10 human genes (ATP2C2, CMIP, CNTNAP2, DCDC2, DYX1C1,
FOXP2, KIAA0319, NFXL1, ROBO1, ROBO2) that had been as-
sociated with language impairment or developmental dyslexia (23,
53). Among them, ATP2C2, which is linked to language impairment
(54), is strongly expressed in Glu neurons specifically in human
(five- or eightfold change vs. chimpanzee or rhesus macaque, ad-
justed P < 1.2e-5), which was concordant with changes in multiple
regulatory features (Dataset S19). In addition, DCDC2, which is
implicated in reading proficiency (55), showed concordant up-
regulation of expression and GRE signals in hominids compared
with rhesus macaque, specifically in MGE-GABA neurons.
Whereas the other eight genes associated with language im-
pairment did not show any concordant evolutionary changes in
their regulation and expression, we detected many human-
specific (and often cell type-specific) DA GREs that were
linked to several of these genes (Dataset S20). Human-specific
enhancers were found in CNTNAP2 (n = 8 in Glu, n = 6 in
MGE-GABA) and FOXP2 (n = 1 in Glu) loci (Fig. 4A and SI
Appendix, Fig. S4 A and B). These two genes have been sug-
gested to be required for the proper development of speech and
language in humans (24–26). The functional importance of these
regulatory changes remains unclear, as we did not observe any
significant human-specific changes in gene expression for FOXP2
or CNTNAP2. Nevertheless, it appears plausible that the in-
crease in regulatory complexity engenders context-dependent
mechanisms of regulation of FOXP2 or CNTNAP2 expression
in anatomical (including brain areas and subpopulations of Glu
or MGE-GABA neurons), environmental, or developmental
contexts, which could, in turn, facilitate the emergence of lan-
guage skills. Notably, cortical areas other than the DLPFC, such
as the inferior frontal cortex and temporal cortex, constitute the
core of the brain language network (56, 57). The evolutionary





















changes in regulation and expression of FOXP2 or CNTNAP2 in
these cortical areas remain to be investigated.
A recent DNA methylation study in the PFC of human and
chimpanzee identified four regions within the CNTNAP2 locus
that were differentially methylated between the two hominids
(58). Remarkably, the region with the largest decrease in DNA
methylation in human vs. chimpanzee (region B in that study)
overlapped with one of the MGE-GABA– and human-specific
up-regulated enhancers detected in our study (Fig. 4A). In ad-
dition, an ASD-linked SNP, rs7794745 (59), which is located
∼280 bp from differentially methylated region B, colocalizes with
the same CNTNAP2 enhancer (Fig. 4A). The major allele nu-
cleotide of rs7794745 (A > T) is a human-specific substitution
compared to other primate species (SI Appendix, Fig. S4C). This
enhancer was also identified and found to be up-regulated in
ASD in a recent H3K27ac study in bulk brain tissues, including the
PFC (Fig. 4A) (60). These findings link a cell-type–specific regu-
latory element that underwent an evolutionary change in humans
to a risk locus associated with a neuropsychiatric disorder.
Human-Specific Up-Regulated GREs Form Neuron Subtype-Dependent
Clusters Located near Genes Associated with Neuronal Function and
Neuropsychiatric Disorders. We found contiguous genomic regions
with a high density of human-specific up-regulated GREs, which
suggested a nonuniform distribution of these GREs across the
genome. This trend is exemplified by an ∼1-Mb-long genomic
region upstream of CDH8 on chromosome 16 that contains a
cluster of 11 human-specific up-DA GREs in Glu neurons (SI
Appendix, Fig. S4D). Applying stringent statistical analysis (Meth-
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Fig. 4. Human-specific up-regulated GREs harbor genes implicated in language, ASD, and opioid addiction. (A) Evolutionary regulatory (H3K27ac and DNA
methylation) and ASD-associated changes at an enhancer within the CNTNAP2 locus in humans (also see SI Appendix, Fig. S4B). The enhancer (shown in a
dashed box) is located within the second intron of CNTNAP2 and shows human-specific up-regulation of the H3K27ac signal in MGE-GABA neurons. Shown
are: ASD-associated SNP rs7794745 (red arrow) (59), the region with the largest decrease in DNA methylation (DNAm) in Hu vs. Ch (green bar) (53), and the
position of an H3K27ac peak (brown bar) that is up-regulated in ASD vs. control subjects (55). (B) The OPRM1 locus shows a high density of Glu human-specific
up-DA GREs (the regions marked as green boxes depict areas with one or several Hu up-DA GREs). The leftmost region exemplifies an evolutionary respe-
cification change from a Rh-enriched enhancer in MGE-GABA to a Hu-enriched enhancer in Glu. (C) H3K27ac profiles within the OPRM1 locus in three species
and two neuronal subtypes. Evolutionary regulatory changes were found within the 5′ region, including human up-regulated promoter and enhancer GREs.
The opioid abuse-associated SNPs rs3778150 and rs1799971 (red arrows) overlap with a human-specific up-DA promoter and human-specific up-DA enhancer,
respectively. (D) Genomic alignment of the 40-bp region centered on the rs1799971 SNP in humans. The human-specific nucleotide substitution at the SNP
position (C → T) is highlighted. Notice a high level of sequence conservation in the immediate vicinity of the SNP. The C nucleotide in humans represents the
minor allele, which has been associated with opioid abuse (65). (E) Evolutionary changes in gene expression of OPRM1 in Glu neurons. Gene-expression
changes were concordant with the regulatory changes, suggesting human-specific and Glu-specific up-regulation of OPRM1.




























GREs over the background distribution of all human GREs in 23
clusters, with 18 and 5 nonoverlapping clusters detected in Glu
and MGE-GABA neurons, respectively (SI Appendix, Fig. S4E).
Four Glu clusters contained a human-specific DE gene (OPRM1,
GULP1, NIT2, PKDCC). Several genes with important roles in the
nervous system or neuropsychiatric disorders overlapped with the
human up-DA GRE clusters. In particular, CDH8 encodes a
neurite outgrowth-regulating membrane protein cadherin-8 and
has been linked to ASD and learning disability (27). Similarly,
ASTN2 is located within a Glu cluster on chromosome 9 and has
been associated with ASD (29). Among the 76 genes located at
Glu-neuronal DA clusters, 9 are associated with ASD according to
the SFARI database (https://www.sfari.org/resource/sfari-gene/)
(61), which is a significant enrichment (P = 0.02 by hyper-
geometric distribution). Notably, recent publications suggest that
human-specific evolutionary changes in gene regulation and ex-
pression could be associated with risk for ASD (14, 62). A pre-
viously described class of human genomic regions that harbor
signatures of human-specific evolutionary changes consists of
human-accelerated regions (HARs) (63). Three of the 18 Glu
clusters overlapped with HARs (HAR2, HAR22, HAR47; Fish-
er’s exact test, P = 0.005), and each of these 3 HARs overlapped
with a human Glu enhancer identified in our study.
We were particularly interested in the cluster containing
OPRM1, a gene that encodes a receptor of endogenous opioid
peptides and is implicated in opioid addiction (Fig. 4 B–E) (20,
21). OPRM1 is expressed in the PFC, and μ-opioid receptor
signaling in the PFC is implicated in altering executive control
and motivational functions, which are important in drug addic-
tion (64). The OPRM1 locus overlaps with one of the Glu clus-
ters on chromosome 6 that contains 17 human- and Glu-specific
up-DA enhancers, as well as a human- and Glu-specific up-DA
promoter (Fig. 4B). Concordant with these regulatory changes,
OPRM1 expression is up-regulated in humans compared with the
two primate species in Glu but not in MGE-GABA neurons
(Fig. 4E). We also found that two human-specific up-DA GREs
within OPRM1 harbor risk SNPs associated with opioid addiction
(rs1799971 and rs3778150), which are situated within the OPRM1
promoter and one of its enhancers, respectively (65, 66)
(Fig. 4C). Strikingly, the major allele nucleotide of rs3778150
(T > C) is a strictly human-specific substitution within a region
that otherwise shows high sequence conservation across mam-
mals (Fig. 4D). The OPRM1 regulatory domain also provides an
example of a respecification event, as it contains an enhancer
that is active in Glu neurons in human but in MGE-GABA
neurons in rhesus macaque (Fig. 4B). Thus, the OPRM1 locus
shows strong evidence of extensive evolutionary changes of its
regulatory landscape that are coupled with concordant changes
in gene expression specific to Glu neurons. In addition to
OPRM1, two other genes implicated in drug abuse, SLC17A8
(discussed above) (Fig. 3J) and PENK (SI Appendix, Fig. S4 F
and G), showed concordant evolutionary changes in gene ex-
pression and regulation. In contrast to OPRM1, the changes in
these two genes were specific to MGE-GABA neurons. Notably,
among the eight genes that comprise the family of opioid ligands
and receptors (OPRM1, OPRD1, OPRK1, OPRL1, POMC, PENK,
PDYN, PNOC), we detected two concordant human-up-regulated
DE genes (OPRM1 and PENK) (enrichment P = 0.01 by hyper-
geometric test). In summary, our findings suggest human-specific
modification of cellular and molecular pathways implicated in
drug addiction.
Discussion
Here, we demonstrate the value of analyzing isolated neuronal
cell populations to increase the sensitivity and specificity of gene
expression and GRE analysis compared with analyses of bulk
cortical tissue. Our findings provide insight into the cell-
type–specific regulatory landscape of the primate brain and its
evolution. Our analyses show that neuron-subtype–specific reg-
ulatory elements preferentially changed during primate evolu-
tion as compared with elements that are active in multiple
neuronal subtypes. This greater evolutionary plasticity of
neuron-subtype–specific GRE suggests that an alteration of a
regulatory element that is beneficial or neutral when it occurs in
a single cell type could be detrimental when it involves multiple
cell or tissue types (67). We also detected regulatory elements
that, despite being active in both Glu and MGE-GABA neurons
of one species, were active in a specific cell type in other species.
Thus, the assumption that a GRE that is active in multiple cell
types (or tissues) represents a functionally conserved regulatory
element is likely to be overly simplistic. Rather, these enhancer
regions might employ different sets of transcription factor
binding sites in different cell types and species, activating distinct
regulatory programs.
Supporting these observations, we identified numerous regu-
latory elements whose activity showed neuron subtype-specific
evolutionary changes in humans (5,259 in Glu and 2,415 in
MGE-GABA). We also detected 165 genes in Glu and 80 genes
in MGE-GABA in humans with strong evidence of concordant
evolutionary changes in their expression and the activity of at
least one GRE. For the majority of these genes, the evolutionary
change was detected across the entire regulatory domain
(quantified as the number of evolved enhancers per gene and the
magnitude of the enhancer H3K27ac signal). These findings
demonstrate the functional importance of regulatory evolution
in different neuronal subtypes. For example, enrichment of
H3K27ac in the promoter and enhancers of the catalase gene
(CAT) in human Glu neurons is associated with a concordant
human-specific up-regulation of gene expression, which could
protect these neurons against oxidative stress caused by the high
metabolic activity of the human brain (47–49). The limitation of
our study is that genes were linked to their putative enhancers
using the distance-based assignment, which is complicated by the
mostly unknown high-order chromatin structure. The latter can
be assessed by genome-wide chromosome conformation capture
(e.g., Hi-C) (68, 69). However, currently, Hi-C data are not avail-
able for Glu or MGE-GABA subtypes, precluding more accurate
linking between promoters and their distal regulatory elements.
Complex spoken language is unique for humans, and the de-
velopment of language was essential to human evolution, through
enabling efficient exchange of information, higher-order social
organization as well as specializations of cognition and symbolic
thinking. Our study emphasizes the importance of regulatory
evolution in the development of language abilities and in the
emergence of disorders associated with language. We identified
two language-associated genes with strong human-specific
(ATP2C2) or hominid-specific (DCDC2) as well as neuron
subtype-dependent concordant changes in expression and regula-
tory landscapes. We also discovered human-specific regulatory
changes in Glu and GABA neurons in the FOXP2 and CNTNAP2
genes that are crucial for brain development, neural plasticity, and
language abilities (2, 25). FOXP2 encodes Forkhead box protein
P2 (FoxP2), a transcription factor that is expressed at high levels in
the brain during fetal development (70). Many FoxP2 targets
(including CNTNAP2) are implicated in schizophrenia and ASD
(71, 72). ASD is characterized by difficulties in social communi-
cation (including language), and previous analyses have uncovered
a link between ASD and HARs, suggesting that certain aspects of
ASD evolved specifically in humans (62). Notably, here we found
that human-specific regulatory elements in neurons are not uni-
formly distributed in the human genome, and that clusters of these
GREs in Glu neurons are enriched for HARs and genes associ-
ated with ASD.
Unexpectedly, we also identified concordant evolutionary
changes in GREs and expression for several genes that have been
implicated in drug addiction, with OPRM1 showing an extensive





















reorganization of its regulatory domain and a pronounced up-
regulation of expression, specifically, in human Glu neurons
compared with chimpanzee and rhesus macaque. BecauseOPRM1
is one of the strongest candidates for affecting risk for opioid-use
disorder (65, 66, 73), our findings suggest that vulnerability to
opioid addiction might have a unique human component. How-
ever, to the best of our knowledge, there is currently no support
for the involvement of regulatory evolution in propensity to opioid
addiction.
The findings presented in this work highlight the importance
of differential regulatory changes in major neuronal subtypes in
brain evolution and brain disorders. These results call for further
analyses that will connect evolutionary changes in regulation
with those in gene expression in multiple subpopulations of
neuronal and glial cells, in different brain areas, and across de-
velopmental trajectories, perhaps using single-cell based ap-
proaches currently under development (16). These future studies
will help to uncover the complex regulatory interaction networks
that underlie the evolution of human brain function and human-
specific traits, and hence will further advance the understanding
of neuropsychiatric disorders.
Methods
Specimens. Human brain specimens (DLPFC tissue samples from four clinically
unremarkable male subjects) were described in Kozlenkov et al. (19) (Dataset
S1). Tissue samples were dissected from the lateral part of Brodmann area 9
(BA9). The rhesus macaque brain tissues were obtained from the Texas
Biomedical Research Institute and California National Primate Research
Center from their established biospecimen distribution programs (Dataset
S1). The chimpanzee brains were obtained from the National Chimpanzee
Brain Resource. Brains of both rhesus macaques and chimpanzees were
collected and snap frozen at the time of necropsy within 5 h or less post-
mortem. The DLPFC was sampled from frozen brains in a region corre-
sponding to BA9 as described in macaques and chimpanzees (74).
Glu and MGE-GABA Nuclei Isolation by FANS. The isolation of nuclei was
performed by FANS as described in Kozlenkov et al. (19). In short, to dis-
tinguish between the two neuronal populations, we employed antibodies
against RNA-Binding Protein RBFOX3 (also known as NeuN; mouse anti-
NeuN, Alexa488-conjugated, MAB377X, Millipore) that is expressed in all
neuronal nuclei, and antibodies against SOX6 (guinea pig anti-SOX6) (75).
SOX6 is a transcription factor that regulates the ontogeny of the MGE-
derived GABA neurons and is robustly expressed in these cells in the adult
human PFC. This experimental approach has been previously validated using
immunocytochemistry, immunohistochemistry, and RNA-seq. (17). As we
previously reported (17), in addition to glutamatergic neurons, the FANS-
isolated Glu population contained a small fraction of non–MGE-GABA
neurons (∼8% of the all sorted Glu neurons) (17). We used ∼800 mg and
150 mg of primate tissue to isolate nuclei for ChIP-seq and RNA-seq, re-
spectively.
ChIP-Seq. H3K27ac ChIP was performed for each subject and neuronal sub-
type as described in refs. 18 and 19, using 100,000 to 150,000 FANS-separated
nuclei and anti-H3K27ac antibody (rabbit polyclonal, Active Motif cat#
39133). We employed the “native” ChIP protocol that uses enzymatic
chromatin fragmentation with micrococcal nuclease (MNase) without cross-
linking proteins to DNA (18, 76). This approach yields ChIP-seq data with a
high signal-to-noise ratio and is, therefore, advantageous for profiling var-
ious histone modifications. ChIP-seq libraries were constructed using the
NEBNext Ultra DNA Library Prep kit (New England Biolabs) as described in
Kozlenkov et al. (19). For each sample, both ChIP and input (MNase-digested
chromatin) libraries were generated and sequenced. Sequencing was per-
formed on an Illumina HiSeq 2500 instrument, using a paired-end 50 (PE50)
protocol to an average of ∼40 million read pairs per sample.
RNA-Seq. RNA was isolated from each subject and neuronal subtype as
previously described (19), using 40,000 FANS-separated nuclei. To preserve
RNA integrity, the RNase inhibitor (Clontech) was added during each step of
the nuclear preparation. Nuclei were sorted directly into tubes containing
3:1 by volume of the Extraction Buffer from PicoPure RNA Isolation kit
(ThermoFisher Scientific). RNA was then extracted from the sorted nuclei
using the PicoPure kit, and the RNA-seq libraries were constructed using
SMARTer Stranded Total Pico-Input RNA-seq kit (Clontech) and 10 ng RNA
from each sample, as previously described (19). Libraries were sequenced on
HiSeq 2500, using PE50 protocol to an average of ∼50 million read pairs
per sample.
Data Availability. The data reported in this paper have been deposited in the
Gene Expression Omnibus database (accession no. GSE158934). The data for
human samples are from Kozlenkov et al. (19), and are available in the
PsychENCODE Knowledge Portal at Synapse (https://doi.org/10.7303/
syn12034263). All other study data and methods are included in SI Appendix
and Datasets S1–S21.
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